20000813
 Boston Scientific Is in Talks to Buy Supplier of Stents   By By John Hechinger, The Wall Street Journal,  Aug 14, 2000  Boston Scientific owns 22% of Medinol, a closely held medical-device company that is the major supplier of stents to the Natick, Mass., company. But difficult relations with Medinol have been a longstanding problem at Boston Scientific and have hampered its ability to bring products to market quickly. A purchase of Medinol would give Boston Scientific greater control of the production of its stent products and of the timing of the product releases.   
